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Figure S1. Loss of LXR expression does not alter macrophage phagocytosis of bacteria 
or fluorescent spheres.  A) Fluorescence microscopic evaluation 1 h after incubation of GFP-
E.Coli with thioglycolate-elicited peritoneal macrophages from WT or LXR DKO (10:1 
ratio).  B) Quantification of total phagocytosis evaluated by fluorescent microscopy.  C) High 
magnification view of WT or LXR DKO macrophages that engulfed fluorescent bacteria.  D) 
Fluorescence microscopic evaluation 1 h after incubation of fluorescent FITC latex beads with 
thioglycolate-elicited peritoneal macrophages from WT or LXR DKO (10:1 ratio).  E) 
Quantification of phagocytosis evaluated by fluorescent microscopy. F) High magnification 
view of WT or LXR DKO macrophages that have engulfed fluorescent latex beads.  
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Figure S2.  LXR agonist promotes the phagocytosis of apoptotic cells in vivo.  WT 
C57/BL6 mice (3 mice/group) were administered 10 mg/kg GW3965 for 3 days. Apoptotic 
cells (108) were fluorescently labeled and inoculated IP.  After 30 or 60 min, uptake of 
apoptotic cells was evaluated by flow cytometry using a CD68 antibody.  Experiment was 
repeated 3 times with comparable results. 
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Figure S3.  Analysis of AT association with peritoneal cells in vivo and AT engulfment by 
dendritic cells.  A) AT do not associate non-specifically with peritoneal B cells.  In vivo 
association of csfe-labeled apoptotic cells with WT or LXR DKO B cells was determined by 
flow cytometry.  Results from 3 separate mice are shown for each genotype.  B) In vivo 
association of csfe-labeled apoptotic cells with WT, Apoe-/- and Abcg1-/- macrophages was 
determined by flow cytometry.  Results from 3 separate mice are averaged for each genotype.  
C) In vivo association of csfe-labeled apoptotic cells with background-matched (B6/129) WT 
and Abca1-/- macrophages was determined by flow cytometry.  Note, Abca1-/- mice on B6 
background are not viable and therefore Abca1-/- macrophages cannot be directly compared 
to C57Bl/6 mice shown in (B).  D) Altered phagocytosis of AT in dendritic cells lacking 
LXRs.  Quantification of phagocytosis by confocal microscopy after incubation of apoptotic 
thymocytes (AT) for 1 h with WT or LXR DKO dendritic cells. Cells were pretreated with 
vehicle or 1 µM GW3965 for 48 h as indicated.  
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Figure S4.  Apoptotic cells do not induce apoptosis in LXR-deficient macrophages.  A) 
Representative  thymus, lung, and testis sections (4 µm) from 40 week-old WT and LXRαβ-/- 
mice were analyzed by TUNEL staining (green) and staining for CD68+ macrophages (red).  
Free apoptotic cells are indicated by arrows (right panel).  B) Spleen sections from WT and 
LXR DKO mice were stained with B220 and TUNEL as indicated. TUNEL+ cells colocalize 
with B cells. Bar represents 25 µm. C,D) Peritoneal macrophages from WT and LXR DKO 
mice show no evidence of cell death after culture for 18 h with AT. C) AT were labeled with 
CMFDA and macrophages stained with F4/80 antibody.  D) Cultures were stained with 
TUNEL, DAPI and F4/80. 
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Figure S5.  LXR WT and LXR DKO thymocytes are equally sensitive to uv irradiation- 
and dexamethasone-induced apoptosis.  Cells obtained from thymi of 4 week-old WT and 
LXR DKO mice were UV irradiated (A) or stimulated with dexamethasone (B) at the 
indicated doses for the indicated times.  Apoptosis was evaluated by flow cytometry with 
AnnexinV staining. 
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Figure S6.  Identification of Mer as an LXR-responsive gene by transcriptional profiling.  
A) Results from microarray analysis of the expression of known LXR targets, TAM family 
members, and receptors involved in macrophage phagocytosis. RAW-LXRα cells were 
stimulated with GW3965 (1µM) and LG268 (100 nM) for 24 h. Total RNA was purified and 
hybridized with Affymetrix 430 v2.0 arrays at the UCLA microarray core and data analyzed 
with GeneSpring GX 7.3 software (Agilent Technologies).  Data are represented as a heat 
map.  B) WT and LXR DKO macrophages were cultured in vitro with GW3965 and LG268 
for 24 h in the presence of 0.5% FBS.  Total RNA was purified and subjected to Northern 
analysis using P32-labeled probes. 
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Figure S7. Direct regulation of Mertk expression by LXR/RXR heterodimers.   
A) Analysis of the mouse Mertk gene promoter revealed a potential LXR response element 
(LXRE) 1.7kb upstream of transcription start site.  Electrophoretic mobility shift assay 
(EMSA) analysis of in vitro translated LXR and RXR protein binding to the Mer LXRE or a 
mutated form of this element. Disruption of this interaction was achieved with an RXR 
antibody.  B) Interaction of FLAG tagged LXR/RXR heterodimers with the Mer LXRE 
evaluated by chromatin immunoprecipitation (ChIP) assays.  RAW-FLAG-LXRα cells were 
stimulated for 1h with GW3965 and subjected to crosslinking and immunoprecipitation with 
anti-IgG control, anti-FLAG and anti-RXR antibodies.  C) ChIP analysis of the interaction of 
PolII and N-CoR with the LXREs in the Mertk and SREBP-1c promoters.  RAW-LXRα cells 
were stimulated for 1h with GW3965 and subjected to crosslinking and immunoprecipitation 
with anti-IgG control, anti-PolII and anti-N-CoR antibodies.  
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Figure S8.  Effect of LXR activation on cytokine production.  Macrophages were 
incubated with AT and treated with TLR ligands as indicated.  Gene expression was analyzed 
by realtime PCR. 
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Figure S9.  Flow cytometric analysis of CD19+B220+ B cells from spleen and lymph 
node of WT and LXR DKO mice. 
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Figure S10.  Absolute cell counts of hematopoetic populations in spleen and lymph node 
of WT and LXR DKO mice determined by flow cytometry.  *P < 0.05, **P < 0.01, ***P < 
0.001. 
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Figure S11.  Flow cytometric analysis of B220+CD3+ (A) and FoxP3+CD4+ (B,C) cell 
populations from spleen and lymph node of WT and LXR DKO mice.  *P < 0.05,  **P < 
0.01. 
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Figure S12.  Lxrαβ-/- mice accumulate IgG-containing immune complexes in multiple 
tissues.  A) Kidneys sections from LXR DKO mice of 12, 24, 36 and 48 weeks of age were 
stained with anti-mouse IgG antibody or DAPI.  Bar represents 50 µm.  B) Skin sections from 
WT and LXR DKO mice at 48 weeks of age were stained with H&E, anti-mouse IgG and 
DAPI.  Bar represents 100 µm. C) Lung sections from WT and LXR DKO mice at 48 weeks 
of age were stained with H&E, anti-mouse IgG, anti-CD68 or anti-CD4.  Bars represent 100 
µm in top panels and 25 µm in the rest of the panels. 
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Figure S13. A) Combined loss of both LXRα  and LXRβ  is required for full 
manifestation of the autoimmune phenotype. Kidney sections from WT, Lxrα-/- Lxrβ-/- 
and LXR DKO mice at 48 weeks of age were stained with anti-mouse IgG antibody or DAPI.  
B) Mice lacking key LXR target genes involved in cholesterol metabolism do not exhibit 
the autoimmune phenotype of Lxrαβ-/- mice.  Kidney sections from WT, LXR DKO, 
ApoE-/-, or Abcg1-/- mice (C57Bl/6 background) at 40 weeks of age were stained with anti-
mouse IgG antibody or H&E.  Kidney sections from Abca1+/+ and Abca1-/- mice 
(C57Bl/6/sv129 mixed strain) at 52 weeks of age stained with anti-mouse IgG antibody or 
H&E. Bars represent 50 µm. 
Table S1.  Glomerulonephritis and altered renal function in LXR deficient mice.   
 
 
 
 
 
 
 
 
 
WT and LXRαβ-/- mice (12/group) were evaluated for survival after 48 weeks. Glomerular 
damage was evaluated on a scale 0-4.  Daily diuresis, urea, creatinine and proteinuria values 
were evaluated in metabolic cages with mice housed individually. 
 
 
 
Survival (%) 
Glomerulonephritis (scale 0-4) 
Duiresis (ml per mouse/day) 
Urine Urea (mg/dL) 
Urine Albumin/Creatinine (ug/mg) 
LXR WT         LXR DKO 
Glomerular Pathology Parameters 
100                      60 
0 ± 0                     2.5 ± 0.7 
0.3 ± 0.11             1.1 ± 0.4 
6150 ± 540           3200 ± 423 
7.4 ± 2.5              24.7 ± 8.2 
